Journal of Enzyme Inhibition and Medicinal Chemistry
12 papers28 directions
The Journal of Enzyme Inhibition and Medicinal Chemistry is a peer-reviewed publication focused on the design, synthesis, and evaluation of biologically active agents. Active within the medicinal chemistry and computational biology space from 2014 to 2025, the venue serves as a platform for research at the intersection of biochemistry and drug discovery. While its primary focus is on enzyme inhibition, the journal features work that utilizes computational tools to identify and optimize chemical leads.
In the context of machine learning and artificial intelligence, the journal functions as an application-oriented venue. It publishes studies employing pharmacophore-based discovery, structure-activity relationship (SAR) evaluations, and high-throughput screening (HTS) optimizations. Research often combines computational modeling with experimental validation to target specific enzymes, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and eosinophil peroxidase (EPO). These methods are used to decipher enzymatic targets and identify new allosteric sites for therapeutic intervention.
Prolific contributors to the venue include researchers such as Thierry Langer, Tiziano Tuccinardi, and Giulio Poli. The published corpus includes investigations into new chemical scaffolds for treating conditions like Alzheimer’s disease and schistosomiasis. By integrating complementary computational tools with traditional medicinal chemistry, the journal facilitates the development of novel inhibitors and the refinement of high-throughput assay techniques.
Papers by Year
| 2025 | 2 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 1 |
| 2018 | 3 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
| Author | Papers |
|---|---|
| Thierry Langer | 3 |
| Chao Zhou | 2 |
| Yu Kang | 1 |
Impactful Papers
Papers from this venue that shaped research clusters.
Influential
High-yield synthesis and purification of recombinant human GABA transaminase for high-throughput scr
influential
Pharmacological Disruption of Neural Osc
2021
Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline sc
influential
Bridging the Cross Species Clinical Tran
2020
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one cor
influential
Computing Molecular Binding Free Energie
2018
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one cor
influential
Optimizing Chemical Scaffolds for Therap
2018
Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline sc
influential
Overcoming the Metabolic Instability of
2020